Intracellular localization of PMPs in CG-G cell lines. Indirect immunofluorescence microscopy was performed with fibroblasts from a healthy control (A, E, I, and M), from a patient with Zellweger syndrome who was assigned to CG-E (B, F, J, and N), and from the patients PBDG-01 (C, G, K, and O), and PBDG-02 (D, H, L, and P). The cells were stained using rhodamine-labeled antibodies to ALDP, a PMP (A–D); fluorescein-labeled antibodies to catalase, a peroxisomal matrix protein (E–H); fluorescein-labeled antibodies to PEX14, a PMP (I–L), or the mitochondrial marker MitoTracker (M–P). In normal fibroblasts, staining with antibodies to ALDP (A), catalase (E), and PEX14 (I) all yielded a punctate pattern, indicating the presence of peroxisomal membranes and intact peroxisomes. Fibroblasts from a patient with Zellweger syndrome who was assigned to CG-E (PBDE) were stained with antibodies to the PMPs ALDP (B) and PEX14 (J). Note the colocalization of the punctate patterns, indicating the presence of peroxisomal membranes. These membranes presumably are nonfunctional peroxisomal ghosts. Incubation with anti-catalase antibodies (F) resulted in a diffuse cytosolic localization, consistent with the absence of intact peroxisomes. In cells of PBDG-01 (C) and PBDG-02 (D), no ALDP positive particles were visible, indicating the complete absence of morphologically detectable peroxisomal membranes. Incubation with anti-catalase antibodies (G and H) exhibited a diffuse cytosolic pattern, consistent with the absence of intact peroxisomes. Staining the cells by use of an antibody specific for PEX14 (K and L) reveals a mitochondrial pattern, as demonstrated by colocalization of PEX14 with MitoTracker (O and P).